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OBJECTIVE — We sought to examine whether age at menarche has changed over the past 4
decades by comparing age at menarche by year of diagnosis with type 1 diabetes.
RESEARCH DESIGN AND METHODS — This work consisted of a cross-sectional
study of age at menarche in two cohorts: adolescents (ages 11–24 years, n  228) and adults
(ages 19–55 years, n  290, enrolled in the Coronary Artery Calciﬁcation in Type 1 Diabetes
study).
RESULTS — The adolescent cohort reported a younger age of menarche than the adult
womenwithtype1diabetes(12.690.08vs.13.220.12years,meanSE,P0.001).Age
at menarche was later in both adolescent girls and adult women with type 1 diabetes diagnosed
before menarche (12.82  1.16 and 13.7  2.23 years) than for individuals diagnosed after
menarche(12.121.25and12.651.38years,P0.001forboth).Ageatmenarchewasthen
examined by decade of type 1 diabetes diagnosis (1970–1979, 1980–1989, 1990–1999, and
2000–2009).Ageatmenarchesigniﬁcantlydeclinedoverthe4decades(P0.0002).However,
the delay in menarche among girls diagnosed with type 1 diabetes before menarche compared
withthosediagnosedaftermenarchewasalsosigniﬁcantacrossalldecades(P0.0001)anddid
not change signiﬁcantly over time (P  0.41 for interaction of cohort and diagnosis
premenarche).
CONCLUSIONS — Age at menarche has declined over the past 4 decades among girls with
type 1 diabetes, but a delay in age at menarche remains among individuals diagnosed before
menarche compared with individuals diagnosed after menarche.
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P
revious studies have demonstrated
that the age of menarche is still de-
layed in girls with type 1 diabetes
(1–5).However,nonehavecomparedage
of menarche of young adolescents with
type 1 diabetes with adult women with
type 1 diabetes to see if the delay in men-
arche has decreased over the past several
decades. Though there is conﬂicting evi-
dence as to whether the age at menarche
in the general population has remained
thesame(6)orhasdeclined(7),therehas
been little research done to look at the
effects of type 1 diabetes on menarchal
timing since the completion of the land-
mark Diabetes Control and Complica-
tions Trial (DCCT) (8), which led to
widespread use of intensive diabetes
treatment. The purpose of this study was
to compare age at menarche by decade of
diabetesdiagnosis,toexaminethetempo-
ral trends in age at menarche in type 1
diabetes.
RESEARCH DESIGN AND
METHODS— Adolescent subjects
were recruited from the pediatric clinic at
the Barbara Davis Center for Childhood
Diabetes. We enrolled females of all eth-
nicities between the ages of 11 and 24
years of age, and individuals who had at
least one menstrual period were included
in the analysis. Subjects with any renal,
respiratory, or cardiac disease and any
other chronic disease besides type 1 dia-
betes were excluded from the study. Sub-
jects with a preexisting diagnosis of
Hashimoto’s thyroiditis were included if
their initial diagnosis was made by close
surveillance and if they had a longstand-
ing history of being clinically and bio-
chemically euthyroid. The study took
place between November 2008 and May
2009. The clinical diabetes type assigned
by the health care provider was obtained
from the medical records and categorized
as type 1 diabetes if the provider assign-
ment was type 1, type 1a, or type 1b dia-
betes (9). A total of 234 subjects were
enrolled in the study, and complete data
on age at menarche and age at diagnosis
wereavailablefor228subjects.Theageof
diagnosis of type 1 diabetes was not avail-
able in four subjects, and two subjects,
both 15 years of age, had not yet started
their menstrual periods. These six sub-
jects were excluded from analysis. There
were 23 subjects with stable treated hy-
pothyroidism included in the analysis.
We also recruited 293 type 1 diabetic
women between ages 19 and 55 years as
part of the Coronary Artery Calciﬁcation
in Type 1 Diabetes study. Inclusion crite-
ria for participants with diabetes were di-
agnosis before the age of 30 years or
positive antibodies or a clinical course
consistent with type 1 diabetes, insulin
therapy within 1 year of diagnosis, and
longstanding diabetes (mean duration 24
years, range 4–52). Despite the use of
these entrance criteria, it is possible that
some women had type 2 diabetes. Partic-
ipants completed a baseline examination
between March 2000 and April 2002 and
afollow-upexaminationbetweenDecem-
ber 2002 and March 2005. Participants
self-reported their reproductive history,
including age at menarche, at the fol-
low-up examination. Complete data were
available for age at menarche and age at
type 1 diabetes diagnosis for 290 of the
293 study participants.
Study approval was obtained from
the institutional review board at the
University of Colorado, Denver, and
participants provided written informed
consent and assent, if appropriate, at
enrollment.
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Age of the ﬁrst menstrual period and
menstrual cycle pattern and length were
obtained by self-report using a question-
naire adapted from the National Health
and Nutrition Examination Survey repro-
ductive health questionnaire (10). Sub-
jects were asked to recall their age at the
time of their ﬁrst menstrual period. Prob-
ing questions were asked to help the sub-
jects if they had difﬁculty remembering
the exact age, such as remembering the
season, grade, or proximity to a birthday.
Statistical analysis
Data are presented as mean  SE. An in-
dependent samples t test was used to test
thedifferenceinageatmenarchebetween
individuals who developed type 1 diabe-
tes before menarche and individuals who
developedtype1diabetesaftermenarche.
Four cohorts were formed based on the
year of type 1 diabetes diagnosis: 1970–
1979, 1980–1989, 1990–1999, and
2000–2009. Multivariate ANOVA was
usedtoexamineageatmenarchebythese
type 1 diabetes diagnosis cohorts and by
diagnosis of type 1 diabetes before versus
after menarche.
RESULTS— Of the 228 adolescent fe-
males with type 1 diabetes, 185 partici-
pantshaddiabetesonsetbeforemenarche
and43werediagnosedwithtype1diabe-
tes after menarche. The overall mean age
of menarche among adolescent females
with type 1 diabetes was 12.69  0.08
years. Girls who developed diabetes be-
foremenarchehadanaverageageofmen-
arche of 12.81  0.09 years compared
with 12.17  0.19 years (P  0.0015) in
individuals who developed diabetes after
menarche.Thedelaybetweenindividuals
diagnosed with type 1 diabetes before
menarcheandindividualsdiagnosedafter
menarche was 0.69  0.20 years in ado-
lescent girls.
In the cohort of adult women partic-
ipating in the Coronary Artery Calciﬁca-
tion in Type 1 Diabetes study, the mean
age at the follow-up examination was
42.8  0.53 years. The overall mean age
of menarche among adult females with
type 1 diabetes was 13.22  0.12 years.
Women who developed diabetes before
menarche(n155)hadanaverageageof
menarcheof13.72.23yearscompared
with 12.65  1.38 years (P  0.0001) in
girls who developed diabetes after men-
arche (n  135). The delay in menarche
between individuals diagnosed with type
1 diabetes before menarche compared
with individuals diagnosed after men-
arche was 1.1  0.22 years in adult
women.
Age at menarche was then examined
by decade of type 1 diabetes diagnosis, as
shown in Fig. 1. Women who were diag-
nosed with type 1 diabetes before 1970
(n  52) were excluded, since there was
notafulldecadeofdataavailableandonly
asmallnumberofstudyparticipantswere
diagnosed in this time frame. The age at
menarche was signiﬁcantly older among
females diagnosed with type 1 diabetes
before menarche (13.32 years [95% CI
13.13–13.52]) compared with girls diag-
nosed with type 1 diabetes after they had
already gone through menarche (12.58
years [12.31–12.85], P  0.0001), with
anoverallmeandelayinmenarcheof0.74
years (95% CI 0.41–1.08). Age at men-
arche declined signiﬁcantly by decade of
type 1 diabetes diagnosis overall (P 
0.0002). This decline in age at menarche
from1970–1979to2000–2009wasonly
signiﬁcant among girls who were diag-
nosed with type 1 diabetes before men-
arche (0.97 years [0.47–1.46], P 
0.0001) and not among girls with men-
arche before the diagnosis with type 1 di-
abetes (0.62 years [0.08 to 1.32], P 
0.08). However, there was no signiﬁcant
interaction between decade of type 1 dia-
betes diagnosis and premenarchal versus
postmenarchal diagnosis of type 1 diabe-
tes on age at menarche (P  0.41).
CONCLUSIONS — This study re-
veals that the age at menarche has signif-
icantly declined over the past 40 years in
girls with type 1 diabetes, but a delay in
menarche persists. Our data also support
the lack of a signiﬁcant decline in age of
menarche in girls with menarche occur-
ring before the diagnosis of type 1 diabe-
tes, similar to reports that the age of
menarche in the general population has
Figure1—Ageatmenarchebytype1diabetes(T1DM)diagnosisyear.
aP0.05forcomparisonwith1970–1979cohort,
bP0.05forcomparison
with 1980–1989 cohort,
cP  0.05 for comparison with 1990–1999 cohort,
dP  0.05 for comparison with 2000–2009 cohort.
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(6), rather than reports of a declining age
of menarche (7). Studies have shown that
the development of rapid- and long-
acting insulin analogs and initiation of in-
sulin pump therapy has helped improve
overall glycemic control (11–13) and that
there has been an improvement in meta-
bolic control, as reﬂected by A1C in chil-
dren, adolescents, and young adults with
type1diabetesoverthelast10years(14).
Improvements in metabolic control have
alreadybeenshowntohavedecreasedthe
frequency of serious complications such
as proliferative retinopathy, nephropa-
thy, and cardiovascular disease seen in
patients with type 1 diabetes (15,16).
Thus, improved glycemic control is also
likely contributing to the decline in age at
menarche.
There were some limitations to our
study. There is the potential for recall
bias with the use of self-reported ques-
tionnaires. However, the age of men-
arche is thought to be reliable by recall,
since it is usually a date that is well re-
membered (17).
In conclusion, more recently diag-
nosed girls with type 1 diabetes report a
younger age at menarche than girls who
werediagnosedinpriordecades.Also,the
delaybetweenindividualsdiagnosedwith
type 1 diabetes before menarche and in-
dividuals diagnosed after menarche is
trendingtobelessinadolescentgirlsthan
in adult women with type 1 diabetes.
Besides the well-reported decrease in
micro- and macrovascular complications
associated improved treatment of type 1
diabetes, reproductive potential may also
haveimproved.However,adelayinmen-
arche of 8 months remains, despite im-
proved diabetes management. More
research is needed in this area so that the
etiology and consequences of delayed age
atmenarcheinthispopulationcanbebet-
ter understood
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